This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.

The present disclosure relates to a series of preparation methods including extraction, separation, purification, and commercialization of ferulic acid, which is a highly functional material from corn brans (a by-product of grain), and more specifically, to a preparation method wherein ferulic acid is extracted from corn brans (a by-product of grain) in high yield by a novel method, and the extracted ferulic acid is separated and purified in high yield and high purity by an economical method, followed by commercialization.

The present disclosure relates to a series of preparation methods including extraction, separation, purification, and commercialization of ferulic acid, which is a highly functional material from corn brans (a by-product of grain), and more specifically, to a preparation method wherein ferulic acid is extracted from corn brans (a by-product of grain) in high yield by a novel method, and the extracted ferulic acid is separated and purified in high yield and high purity by an economical method, followed by commercialization.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

The technology disclosed herein concerns a family of alkoxybenzophenones for use as photoinitiators for crosslinking polyolefins.

The technology disclosed herein concerns a family of alkoxybenzophenones for use as photoinitiators for crosslinking polyolefins.

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.